Humana Updates Medicare Advantage Coverage for AngioDynamics NanoKnife
Humana updated its Medicare Advantage coverage policy supporting broader access to AngioDynamics’ NanoKnife irreversible electroporation treatment for prostate and liver cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.